Prognostic Impact of KRAS Mutation Subtypes in 677 Patients with Metastatic Lung Adenocarcinomas
Helena A. Yu(Memorial Sloan Kettering Cancer Center), Gregory J. Riely(Memorial Sloan Kettering Cancer Center), Wade T. Iams(Centerstone), Mark G. Kris(American Society of Clinical Oncology), Geoffrey R. Oxnard(Boston Medical Center), Marc Ladanyi(Memorial Sloan Kettering Cancer Center), Leora Horn(Chinese University of Hong Kong), Samantha L. Kass(Memorial Sloan Kettering Cancer Center), Christine M. Lovly(Vanderbilt University), Alice T. Shaw(Massachusetts General Hospital), Justin F. Gainor(Massachusetts General Hospital), Ronglai Shen(Memorial Sloan Kettering Cancer Center), Megan Hames(Vanderbilt-Ingram Cancer Center), Jonathan Aston(Vanderbilt-Ingram Cancer Center), Christine Lydon(Dana-Farber Cancer Institute), Camelia S. Sima(Memorial Sloan Kettering Cancer Center)
Cited by 138
Related Papers
Comprehensive molecular characterization of gastric adenocarcinoma
|Nature|2014|6.5k
International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma
|Journal of Thoracic Oncology|2011|4.8k
Tumor mutational load predicts survival after immunotherapy across multiple cancer types
|Nature Genetics|2019|4.4k
The landscape of somatic copy-number alteration across human cancers
|Nature|2010|4.1k
First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer
|New England Journal of Medicine|2018|3.5k